First Trust Advisors’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.54M | Buy |
+239,045
| New | +$3.54M | ﹤0.01% | 1542 |
|
|
2023
Q3 | – | Sell |
-13,577
| Closed | -$209K | – | 2491 |
|
|
2023
Q2 | $209K | Buy |
+13,577
| New | +$209K | ﹤0.01% | 2290 |
|
|
2023
Q1 | – | Sell |
-72,743
| Closed | -$1.53M | – | 2477 |
|
|
2022
Q4 | $1.53M | Sell |
72,743
-34,122
| -32% | -$718K | ﹤0.01% | 1815 |
|
|
2022
Q3 | $2.63M | Buy |
106,865
+57,491
| +116% | +$1.42M | ﹤0.01% | 1560 |
|
|
2022
Q2 | $1.2M | Buy |
+49,374
| New | +$1.2M | ﹤0.01% | 1919 |
|
|
2021
Q3 | – | Sell |
-22,761
| Closed | -$332K | – | 2637 |
|
|
2021
Q2 | $332K | Sell |
22,761
-90,087
| -80% | -$1.31M | ﹤0.01% | 2357 |
|
|
2021
Q1 | $2.82M | Buy |
112,848
+67,424
| +148% | +$1.68M | ﹤0.01% | 1587 |
|
|
2020
Q4 | $1.24M | Buy |
+45,424
| New | +$1.24M | ﹤0.01% | 1809 |
|
|
2019
Q2 | – | Sell |
-48,227
| Closed | -$1.09M | – | 2501 |
|
|
2019
Q1 | $1.09M | Sell |
48,227
-18,807
| -28% | -$425K | ﹤0.01% | 1828 |
|
|
2018
Q4 | $1.52M | Sell |
67,034
-93,844
| -58% | -$2.12M | ﹤0.01% | 1619 |
|
|
2018
Q3 | $4.62M | Buy |
160,878
+91,513
| +132% | +$2.63M | 0.01% | 1189 |
|
|
2018
Q2 | $1.89M | Buy |
+69,365
| New | +$1.89M | ﹤0.01% | 1652 |
|